Precision BioSciences, Inc. Common Stock (DTIL) — Analysis Summary
Precision BioSciences, Inc. Common Stock (DTIL) has a market cap of $179.84M with year-over-year revenue growth of -50.1%. Net margin stands at -133.4%. The stock trades at a P/E ratio of -4.1.
Key Takeaways
- Revenue changed -50.1% year-over-year
- Net margin of -133.4%
- P/E ratio of -4.1
Compared to other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, DTIL posted revenue growth of -50.1% and trades at a P/E of -4.1.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.